Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | N,N,N-Tributylbutan-1-aminium hydrogen sulfate sulfate 2-sulfodioxidan-1-ide (5/1/1/2) | HCID 16218505 | — |
| Reactant | HCID 58124920 | HCID 58124920 | — |
| Reactant | HCID 58124951 | HCID 58124951 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 66919892 | HCID 66919892 | — |
Reaction Steps
A solution of 350 mg of 23d, and 20g of Mn(III)TPPP(OAc) and 75 mg of imidazole in 20 ml of dichloromethane were treated with tetrabutylammonium oxone, according to a described procedure; D. Mohajer et al., Tetr. Letters, 45, 3811 (2004). This provide after work-up, and chromatographic purification on silicagel (using a gradient of CH2Cl2 and ethyl acetate as eluent) 160 mg of crystalline 23e (triturated with diisopropyl ether); Mp 227° C. Rf (CH2Cl2-ethyl acetate 1/1) 0.61. LC-MS-ESI: [M+1] 522.97 and 524.99. NMR (CDCl3) δ 1.28 (t, 3, ethyl), 3.38 (q, 2, ethyl), 1.58 (s, 9, tertC4H9), 4.00 (s, 3, OCH3), 8.89 and 6.89 (2×s, 2, Ar—H), 4.50 and 3.85 (2×m, 2, CH2), 3.80 and 3.50 (2×m, 2, CH2), 3.05 (m, 2, CH2), 2.70 (m, 2, CH2) 1.90-1.65 (2×m, 4, 2×CH2).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08431564B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-ef2c96293de84430b0be27a2383873f5 |
|---|
| Source note | uspto-grants-2013_04 |
|---|